Detailed information for compound 57361

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 433.381 | Formula: C21H18F3N3O4
  • H donors: 3 H acceptors: 4 LogP: 0.32 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: OC[C@@H]1C[C@@H](CN1c1cc2n(cc(c(=O)c2cc1F)C(=O)O)c1ccc(cc1F)F)N
  • InChi: 1S/C21H18F3N3O4/c22-10-1-2-17(15(23)3-10)27-8-14(21(30)31)20(29)13-5-16(24)19(6-18(13)27)26-7-11(25)4-12(26)9-28/h1-3,5-6,8,11-12,28H,4,7,9,25H2,(H,30,31)/t11-,12-/m0/s1
  • InChiKey: ZNAOHBXEDPYIDO-RYUDHWBXSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni hypothetical protein 0.1164 0.2152 1
Loa Loa (eye worm) kinesin-like protein KLP2 0.0174 0.0166 0.2718
Schistosoma mansoni kinesin eg-5 0.0174 0.0166 0.077
Schistosoma mansoni Protoporphyrinogen oxidase chloroplast/mitochondrial precursor 0.0395 0.061 0.2834
Trypanosoma cruzi UDP-galactopyranose mutase 0.0395 0.061 0.5
Loa Loa (eye worm) hypothetical protein 0.0395 0.061 1
Entamoeba histolytica kinesin, putative 0.0174 0.0166 0.5
Mycobacterium ulcerans flavin-containing monoamine oxidase AofH 0.5075 1 1
Plasmodium vivax lysine-specific histone demethylase 1, putative 0.0395 0.061 1
Plasmodium falciparum lysine-specific histone demethylase 1, putative 0.0395 0.061 1
Brugia malayi hypothetical protein 0.0395 0.061 1
Leishmania major UDP-galactopyranose mutase 0.0395 0.061 0.5
Brugia malayi Kinesin motor domain containing protein 0.0174 0.0166 0.2718
Trypanosoma cruzi UDP-galactopyranose mutase 0.0395 0.061 0.5
Echinococcus multilocularis kinesin family 1 0.1337 0.2501 1
Plasmodium falciparum conserved Plasmodium protein, unknown function 0.0395 0.061 1
Echinococcus granulosus kinesin family 1 0.1337 0.2501 1
Mycobacterium tuberculosis Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) 0.468 0.9207 1
Toxoplasma gondii histone lysine-specific demethylase 0.0395 0.061 1
Loa Loa (eye worm) hypothetical protein 0.0395 0.061 1
Schistosoma mansoni Lysine-specific histone demethylase 1 0.0395 0.061 0.2834
Loa Loa (eye worm) hypothetical protein 0.0395 0.061 1
Plasmodium vivax hypothetical protein, conserved 0.0395 0.061 1
Loa Loa (eye worm) hypothetical protein 0.0395 0.061 1
Plasmodium vivax hypothetical protein, conserved 0.0395 0.061 1
Brugia malayi SWIRM domain containing protein 0.0395 0.061 1
Onchocerca volvulus 0.0395 0.061 1
Schistosoma mansoni amine oxidase 0.0395 0.061 0.2834
Brugia malayi amine oxidase, flavin-containing family protein 0.0395 0.061 1
Loa Loa (eye worm) hypothetical protein 0.0395 0.061 1
Loa Loa (eye worm) hypothetical protein 0.0395 0.061 1
Toxoplasma gondii histone lysine-specific demethylase LSD1/BHC110/KDMA1A 0.0395 0.061 1
Giardia lamblia Kinesin-5 0.0174 0.0166 0.5
Plasmodium falciparum protoporphyrinogen oxidase 0.0395 0.061 1
Plasmodium vivax protoporphyrinogen oxidase, putative 0.0395 0.061 1
Mycobacterium leprae PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) 0.0395 0.061 0.5
Chlamydia trachomatis protoporphyrinogen oxidase 0.0395 0.061 0.5
Schistosoma mansoni amine oxidase 0.0395 0.061 0.2834

Activities

Activity type Activity value Assay description Source Reference
I50 (functional) = 10 ug ml-1 Supercoiling inhibition assay using purified DNA gyrase isolated from Escherichia coli H560 ChEMBL. 2840501
IC50 (functional) = 10 ug ml-1 Supercoiling inhibition assay using purified DNA gyrase isolated from Escherichia coli H560 ChEMBL. 2840501
MIC (functional) = 1.56 ug ml-1 In vitro Minimum inhibitory concentration against Staphylococcus aureus ATCC 6538P ChEMBL. 2840501
MIC (functional) = 3.1 ug ml-1 In vitro Minimum inhibitory concentration against Escherichia coli Juhl ChEMBL. 2840501
MIC (functional) = 3.1 ug ml-1 In vitro Minimum inhibitory concentration against Klebsiella pneumoniae 8045 ChEMBL. 2840501
MIC (functional) = 3.1 ug ml-1 In vitro Minimum inhibitory concentration against Escherichia coli Juhl ChEMBL. 2840501
MIC (functional) = 6.2 ug ml-1 In vitro Minimum inhibitory concentration against Staphylococcus aureus CMX 686B ChEMBL. 2840501
MIC (functional) = 6.2 ug ml-1 In vitro Minimum inhibitory concentration against Staphylococcus aureus A5177 ChEMBL. 2840501
MIC (functional) = 12.5 ug ml-1 In vitro Minimum inhibitory concentration against Staphylococcus aureus 45 ChEMBL. 2840501
MIC (functional) = 12.5 ug ml-1 In vitro Minimum inhibitory concentration against S. epidermidis 3519 ChEMBL. 2840501
MIC (functional) = 12.5 ug ml-1 In vitro Minimum inhibitory concentration against S. agalactiae CMX 508 ChEMBL. 2840501
MIC (functional) = 12.5 ug ml-1 In vitro Minimum inhibitory concentration against Pseudomonas aeruginosa 5007 ChEMBL. 2840501
MIC (functional) = 12.5 ug ml-1 In vitro Minimum inhibitory concentration against Pseudomonas aeruginosa K799/WT ChEMBL. 2840501
MIC (functional) = 25 ug ml-1 In vitro Minimum inhibitory concentration against S. faecium ATCC 8043 ChEMBL. 2840501
MIC (functional) = 25 ug ml-1 In vitro Minimum inhibitory concentration against S. pyogenes 930 ChEMBL. 2840501
MIC (functional) = 25 ug ml-1 In vitro Minimum inhibitory concentration against Acinetobacter CMX 669 ChEMBL. 2840501
MIC (functional) = 50 ug ml-1 In vitro Minimum inhibitory concentration against S. bovis A5169 ChEMBL. 2840501
Solubility (ADMET) = 0.06 mg ml-1 Compound was evaluated for the solubility in Ringer's buffer solution ChEMBL. 2840501

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Escherichia coli ChEMBL23 2840501

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.